MedPath
HSA Approval

WALESOLONE SYRUP 10 mg/5 ml

SIN07848P

WALESOLONE SYRUP 10 mg/5 ml

WALESOLONE SYRUP 10 mg/5 ml

September 17, 1994

M.B.D. MARKETING (S) PTE LTD

M.B.D. MARKETING (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantM.B.D. MARKETING (S) PTE LTD
Licence HolderM.B.D. MARKETING (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

H02AB06

prednisolone

Manufacturer Information

m.b.d. marketing (s) pte ltd

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

PREDNISOLONE

10 mg/5 ml

Prednisolone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.